These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 6254636

  • 1. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW, Cheng YC, Schabel FM, Montgomery JA.
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL, Shaddix SC, Brockman RW, Bennett LL.
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [Abstract] [Full Text] [Related]

  • 3. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
    Cass CE, Selner M, Phillips JR.
    Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904
    [Abstract] [Full Text] [Related]

  • 4. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
    Barrueco JR, Jacobsen DM, Chang CH, Brockman RW, Sirotnak FM.
    Cancer Res; 1987 Feb 01; 47(3):700-6. PubMed ID: 3802076
    [Abstract] [Full Text] [Related]

  • 5. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 6. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
    Verhoef V, Sarup J, Fridland A.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4478-83. PubMed ID: 6272978
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
    Cass CE, Au-Yeung TH.
    Cancer Res; 1976 Apr 01; 36(4):1486-91. PubMed ID: 944095
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
    Roberts D, Peck C, Hilliard S, Wingo W.
    Cancer Res; 1979 Oct 01; 39(10):4048-54. PubMed ID: 476642
    [Abstract] [Full Text] [Related]

  • 9. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov 01; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 10. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT, Craig RW, Agarwal RP.
    Cancer Res; 1980 Sep 01; 40(9):3286-92. PubMed ID: 7427943
    [Abstract] [Full Text] [Related]

  • 11. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI, Plunkett W.
    Cancer Res; 1982 Jul 01; 42(7):2587-91. PubMed ID: 7083151
    [Abstract] [Full Text] [Related]

  • 12. Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
    Sato A, Montgomery JA, Cory JG.
    Cancer Res; 1984 Aug 01; 44(8):3286-90. PubMed ID: 6611198
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
    LePage GA, Worth LS, Kimball AP.
    Cancer Res; 1976 Apr 01; 36(4):1481-5. PubMed ID: 946595
    [Abstract] [Full Text] [Related]

  • 14. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
    Gandhi V, Plunkett W.
    Cancer Res; 1988 Jan 15; 48(2):329-34. PubMed ID: 3335008
    [Abstract] [Full Text] [Related]

  • 15. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
    Rodriguez CO, Mitchell BS, Ayres M, Eriksson S, Gandhi V.
    Cancer Res; 2002 Jun 01; 62(11):3100-5. PubMed ID: 12036920
    [Abstract] [Full Text] [Related]

  • 16. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.
    White JC, Capizzi RL.
    Cancer Res; 1991 May 15; 51(10):2559-65. PubMed ID: 2021937
    [Abstract] [Full Text] [Related]

  • 17. Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.
    Danhauser L, Plunkett W, Liliemark J, Gandhi V, Iacoboni S, Keating M.
    Leukemia; 1987 Sep 15; 1(9):638-43. PubMed ID: 3478543
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
    Cass CE, Tan TH, Selner M.
    Cancer Res; 1979 May 15; 39(5):1563-9. PubMed ID: 85484
    [Abstract] [Full Text] [Related]

  • 19. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
    Balzarini J, De Clercq E.
    Mol Pharmacol; 1983 Jan 15; 23(1):175-81. PubMed ID: 6306422
    [Abstract] [Full Text] [Related]

  • 20. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM, Kuiper CM, Voorn DA, Comijn EM, Myhren F, Sandvold ML, Hendriks HR, Peters GJ.
    Biochem Pharmacol; 2004 Feb 01; 67(3):503-11. PubMed ID: 15037202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.